SCHEMBL8684394

SCHEMBL8684394

[CH2]C(CCC)C(=O)OCCC

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 2/20 0.38
HDAC2 Q92769 2/20 0.38
HDAC7 Q8WUI4 2/20 0.38
HDAC8 Q9BY41 2/20 0.38
HDAC6 Q9UBN7 2/20 0.38
HDAC9 Q9UKV0 2/20 0.38
HDAC5 Q9UQL6 2/20 0.38
HDAC3 O15379 1/20 0.38
HDAC4 P56524 1/20 0.38
HDAC10 Q969S8 1/20 0.38
HDAC11 Q96DB2 1/20 0.38
HCAR2 Q8TDS4 1/20 0.38
ALDH1A1 P00352 3/20 0.36
CHRM1 P11229 2/20 0.36
TDP1 Q9NUW8 2/20 0.36
AKR1A1 P14550 1/20 0.36
CHRM3 P20309 1/20 0.36
HTR2A P28223 1/20 0.36
HTR2C P28335 1/20 0.36
ADRA1A P35348 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5323280 0.87 CA2 (0.42) ALDH1A1TDP1TSHRCYP3A4HPGD
SCHEMBL2167263 0.87 ALDH1A1 (0.50) HCAR2ALDH1A1TDP1LMNATSHR
SCHEMBL1387656 0.84 ALDH1A1 (0.42) HDAC1HDAC2ALDH1A1CHRM1TDP1
SCHEMBL127777 0.84 HCAR2 (0.39) HCAR2ALDH1A1CHRM1TDP1LMNA
SCHEMBL4366941 0.81 L3MBTL1 (0.44) ALDH1A1TDP1LMNATSHRCYP3A4
SCHEMBL2166892 0.79
SCHEMBL27756273 0.78 TSHR (0.45) HDAC1HDAC2HDAC7HDAC8HDAC6
SCHEMBL3635010 0.78 HCAR2 (0.41) HDAC1HDAC2HDAC7HDAC8HDAC6
SCHEMBL2448748 0.76 HDAC1 (0.58) HDAC1HDAC2HDAC7HDAC8HDAC6
SCHEMBL4776137 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5723481-A ANTIULCER AGENTS AND 5-LIPOXYGENASE INHIBITORS SANKYO COMPANY, LIMITED (JP) 1998-03-03 US disclosed
US-5698576-A POSSESS ANTI-ULCER AND 5-LIPOXYGENASE INHIBITORY ACTIVITIES SANKYO COMPANY, LIMITED (JP) 1997-12-16 US disclosed
US-5665752-A LIPOXYGENASE INHIBITORS SANKYO COMPANY, LIMITED (JP) 1997-09-09 US disclosed
US-5354768-A Use of imidazopyrazole derivatives as analgesics and anti-inflammatory agents SANKYO COMPANY, LIMITED (JP) 1994-10-11 US disclosed
EP-0353047-B1 Use of imidazopyrazole derivatives as analgesics and anti-inflammatory agents SANKYO CO (JP) 1994-10-05 EP disclosed
US-5232939-A Use of imidazopyrazole derivatives as analgesics and anti-inflammatory agents SANKYO COMPANY LIMITED (JP) 1993-08-03 US disclosed
EP-0353047-A2 Use of imidazopyrazole derivatives as analgesics and anti-inflammatory agents Sankyo Company Limited (JP) 1990-01-31 EP disclosed